Genomictree, Inc. is a molecular diagnostic company focused on developing epigenomic biomarker-based technologies to address unmet needs in the healthcare market. By leveraging innovative methodologies, Genomictree aims to enhance the accuracy and effectiveness of molecular diagnostics, ultimately contributing to improved patient outcomes. The company is dedicated to advancing the field of personalized medicine through its specialized diagnostic solutions.
OPTOLANE Technologies is a biotechnology company that develops a diagnosis platform.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.